Hepatitis A antibody prevalence among young adults in Israel – the decline continues

M. GDALEVICH; I. GROTTO; Y. MANDEL; D. MIMOUNI; J. SHEMER; I. ASHKENAZI

doi:10.1017/S0950268898001198

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

This study sought to determine whether the decline in prevalence of hepatitis A virus (HAV) antibodies detected in Israel in 1977, 1984, and 1987 has continued. The anti-HAV antibody prevalence of a systematic sample of 578 male and female recruits inducted into the Israel Defence Force in 1996 was 38·4%. The reduction in antibody prevalence from 1977 (64%) was highly significant (P<0·001). There was a smaller decrease rate in recruits of European, North American, Australian and South African origin than from elsewhere. A ‘strategy’ that uses active immunization against hepatitis A (inactivated vaccine, instead of gamma globulin) should be considered, particularly in high risk groups such as field units during military service.

Crossref Citations

This article has been cited by the following publications. This list is generated based on data provided by Crossref.

Lees, David 2000. Viruses and bivalve shellfish. International Journal of Food Microbiology, Vol. 59, Issue. 1-2, p. 81.

Lee, Shou‐Dong 2000. Asian perspectives on viral hepatitis A. Journal of Gastroenterology and Hepatology, Vol. 15, Issue. s3,

Gillis, David Yetiv, Nir Gdalevich, Michael Mimouni, Daniel Ashkenazi, Isaac Shpilberg, Ofer Eldad, Arieh and Shemer, Joshua 2000. Active versus passive immunization against hepatitis A in the Israel defence forces: a cost–benefit analysis. Vaccine, Vol. 18, Issue. 26, p. 3005.

ASHKENAZI, MALKA CHODIK, GABRIEL LITTNER, MARK ALONI, HAVA and LERMAN, YEHUDA 2001. The presence of hepatitis A antibodies in dental workers. The Journal of the American Dental Association, Vol. 132, Issue. 4, p. 492.

Gillis, David Grotto, Itamar Mimouni, Daniel Huerta, Michael Gdalevich, Michael and Shpilberg, Ofer 2002. Adult infection with hepatitis A despite declining endemicity; in favor of adult vaccination. Vaccine, Vol. 20, Issue. 17-18, p. 2243.

LIVNI, GILAT PLOTKIN, SIMION YUHAS, YAEL CHODIK, GABRIEL ALONI, HAVA LERMAN, YEHUDA and ASHKENAZI, SHAI 2002. Seroepidemiology of hepatitis A antibodies among children’s hospital staff. The Pediatric Infectious Disease Journal, Vol. 21, Issue. 7, p. 618.

ACHARYA, SUBRAT KUMAR BATRA, YOGESH BHATKAL, BHARATI OJHA, BANDANA KAUR, KULDEEP HAZARI, SIDDARTH SARAYA, ANOOP and PANDA, SUBRAT KUMAR 2003. Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: Implications for HAV vaccination. Journal of Gastroenterology and Hepatology, Vol. 18, Issue. 7, p. 822.

Linneberg, Allan Østergaard, Christian Tvede, Michael Andersen, Leif Pervical Nielsen, Niels Henrik Madsen, Flemming Frølund, Lars Dirksen, Asger and Jørgensen, Torben 2003. IgG antibodies against microorganisms and atopic disease in Danish adults: The Copenhagen Allergy Study. Journal of Allergy and Clinical Immunology, Vol. 111, Issue. 4, p. 847.

Schoub, Barry 2003. International Handbook of Foodborne Pathogens.

Franco, Elisabetta Giambi, Cristina Ialacci, Rita Coppola, Rosa C. and Zanetti, Alessandro R. 2003. Risk groups for hepatitis A virus infection. Vaccine, Vol. 21, Issue. 19-20, p. 2224.

Samuels, Noah 2005. Routine testing for IgG antibodies against hepatitis A virus in Israel. BMC Public Health, Vol. 5, Issue. 1,

Bell, Beth P 2005. Viral Hepatitis. p. 126.

Hussain, Zahid Das, Bhudev C Husain, Syed A Murthy, Nandagudi S and Kar, Premashis 2006. Increasing trend of acute hepatitis A in north India: Need for identification of high‐risk population for vaccination. Journal of Gastroenterology and Hepatology, Vol. 21, Issue. 4, p. 689.

Orr, Nadav Klement, Eyal Gillis, David Sela, Tamar Kayouf, Raid Derazne, Estela Grotto, Itamar Balicer, Ran Huerta, Michael Aviram, Lisa Ambar, Ruhama Epstein, Yoram Heled, Yuval and Cohen, Dani 2006. Long-term immunity in young adults after a single dose of inactivated Hepatitis A vaccines. Vaccine, Vol. 24, Issue. 20, p. 4328.

Chodick, Gabriel Green, Manfred S. Heymann, Anthony D. Rosenmann, Lena and Shalev, Varda 2007. The shifting epidemiology of hepatitis A following routine childhood immunization program in Israel. Preventive Medicine, Vol. 45, Issue. 5, p. 386.

Chodick, G. Heymann, A. D. Ashkenazi, S. Kokia, E. and Shalev, V. 2008. Long‐term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program. Journal of Viral Hepatitis, Vol. 15, Issue. s2, p. 62.

Fiore, Anthony E. Feinstone, Stephen M. and Bell, Beth P. 2008. Vaccines. p. 177.

Fiore, Anthony E. and Bell, Beth P. 2009. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. p. 2194.

WASLEY, ANNEMARIE FEINSTONE, STEPHEN M. and BELL, BETH P. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. p. 2367.

Murphy, Trudy V. Feinstone, Stephen M. and Bell, Beth P. 2013. Vaccines. p. 183.

Download full list

Article contents

Hepatitis A antibody prevalence among young adults in Israel – the decline continues

Abstract

Save article to Kindle

Save article to Dropbox

Save article to Google Drive

Reply to: Submit a response

Your details

You have entered the maximum number of contributors

Conflicting interests